REFERENCES
  1. Shen.L, Xie.X, Su.Y, Luo.C, Zhang.C and Zeng.B. Parathyroid Hormone versus Bisphosphonates Treatment on Bone Mineral Density in Osteoporosis Therapy: A Meta-Analysis of Randomized controlled Trials. PLoS One A Peer-Reviewed Open Access Journal . 2011; 6 (10)
  2. Yang.Y, Zhang.X, Zhu.X, Zhang.L, Bao.M, Xian.Y, Wu.J, Mei.L, Li.P. Comparison between Recombinant Parathyroid Hormone (1-34) and elcatonin in treatment of primary osteoporosis. Asian Pacific Journal of Tropical Medicine . 2015;79-84
  3. Lane.N. Epidemiology, etiology and diagnosis of osteoporosis. American Journal of Obstetrics and Gynecology. 2006; 194: s3-s11.
  4. Tian, MD.L, Xang, Msc.R, Wei, MD.L, Liu, MD.J, Yang, MD.Y, Shao, Msc.F, Ma, Msc.W, Li, Msc.T, Wang, Msc.Y, Guo, Md.T. Prevalence of osteoporosis and related life style and Metabolic factors of postmenopausal women and elderly men: A cross sectional study in Gansu Province, North western of China. Medicine; October 2017, vol.96 (43); pe 8294.
  5. Haris.S, Jahan.F, Afreen.A, Ahmed.H and Ahmed.Z. Osteoporosis among Adult Pakistani Population Residing in Karachi Using Quantitative ultrasound Technique. Community Medicine & Health Education. 2014; 4:4
  6. Elliot.M. Prevention and Management of Osteoporosis. The Journal of Pharmacy Society of Wisconsin . 2010; 29-41.
  7. Liu.Y, Dvornyk.V, Lu.Y, Shen.H, Lappet.J, Recker.R and Deng.H. A Novel Pathophysiological Mechanism for Osteoporosis suggested by an In Vivo Gene Expression Study of Circulating Monocytes. The Journal of Biological Chemistry. Vol.280 no.32 p.29011-29016.
  8. Lin.X, Xiong.D, Peng.Y, Sheng.Z, Wu.X, Wu.X, Wu.F, Yuan.L and Liao.E. Epidemiology and Management of Osteoporosis in People’s Republic of China: Current perspectives. Clinical Interventions in Aging . 2015; 10: 1017-1033.
  9. Dobbs.M, Buckwalter.J, Saltzman.C. “Osteoporosis the Increasing Role of Orthopaedist.” The IOWA ORTHOPAEDIC JOURNAL. 1999; 19: 43-52.
  10. Faienza.M, Ventura.A, Marzano.F, Cavallo.L. Postmenopausal Osteoporosis: The Role of Immune System Cells. Hindawi Journal of Immunology Research . Vol.2013 (2013) p6.
  11. Sozen.T, Ozisik.L, basaran.N. An overview and management of osteoporosis. European Journal of Rheumatology . Vol.4 (1); 2017 Mar.
  12. Mirza.F and Canalis.E. SECONDARY OSTEOPOROSIS: PATHOPHYSIOLOGY AND MANAGEMENT. European Journal of Endocrinology . 2015 Sep; 17 (3): R131-R151.
  13. Miazgowski.T, Kleevekoper.M, Felsenberg.D, Stepan.J and Szulc.P. Secondary Osteoporosis: Endocrine and Metabolic Causes of Bone Mass Deterioration. Journal of Osteoporosis . Vol. 2012 (2012); 2 pages.
  14. Sie-Marie.L. OSTEOPOROSIS: PATHOPHYSIOLOGY AND BONE REMODELING.JOURNAL Society of Obstetricians and Gynecologists Canada. December 1995; 17: 1205-09.
  15. Souza.M. OSTEOPOROSIS DIAGNOSIS AND TREATMENT. Revista Brasileria de Ortopedia . 2011 May-Jun; 43(3): 2220-2229.
  16. Kostecra.M. The role of healthy diet in the prevention of osteoporosis in postmenopausal period. Pakistan Journal of Medical Sciences . 2014 Jul-Aug; 30(4): 763-768.
  17. Cashman.K. Diet, nutrition and Bone health. The Journal of Nutrition. Vol.137(11): 2507S-2512S
  18. Sweet.M, Sweet.J, Jeremiah.M, Galazka.S. Diagnosis and Treatment of Osteoporosis. American Family Physician . Vol.79 (3); 2009: 193-200.
  19. Reid.I, Grainger.R. Prevention of Osteoporosis. Biomedical and Pharmacology Journal. Issue 17: 6-13.
  20. Schrager.S. Osteoporosis Prevention in Primary Care. WISCONSIN MEDICAL JOURNAL. 2003, Vol.102 (3): 52-55.
  21. Gabriele.P. Risk factor identification and prevention o osteoporosis in primary care setting. Malta Medical Journal . 18(01): 40-45.
  22. Lin.J, Lane.J. Non pharmacologic Management of Osteoporosis to Minimize Fracture Risk. Nature Clinical Practice Rheumatology. 2008; 4(1): 20-25.
  23. Cosma.F, Beur.S, LeBoff.M, Lewiecki.E, Tanner.B, Randall.S and Lindsay.R. Clinician’s Guide to Prevention and Treatment of Osteoporosis. Osteoporosis International . 2014; 25(10): 2359-3381.
  24. Gehrig.L, Lane.J and O’connor.M. Osteoporosis: Management and Treatment strategies for Orthopedic Surgeons. The Journal of Bone and Joint Surgery . 2008; 90: 1362-1374.
  25. Fleisch.H. Bisphosphonates in Osteoporosis. European Spine Journal . 2003 Oct; 12 (suppl.2): s142-s146.
  26. Sinigaglia.L, Varenna.M and Casari.S. Pharmacokinetic Profile of Bisphosphonates in the Treatment of Metabolic bone disorders.Clinical Cases in Mineral and Bone Metabolism . 2007 Jan-Apr; 4(1): 30-36.
  27. Russel.R, Rogers.M, Frith.J, Luckman.S, Coxon.F, Benford.H, Croucher.P, Shipman.C and Flerisch.H. The Pharmacology of Bisphosphonates and New Insights into Their Mechanism of Action. Journal of Bone and Mineral Research . 1999; Vol. 14(suppl.2): 53-65.
  28. Byun.J, Jang.S, Lee.S, Park.S, Yoon.H, Yoon.B and Ha.Y. The Efficacy of Bisphosphonates for Prevention of Osteoporotic Fractures. An Update Meta-Analysis. Journal of Bone Metabolism . 2011 Feb; 24(1): 37-49.
  29. Kennel.K and Drake.M. Adverse Effects of Bisphosphonates: Implication for Osteoporotic Management. Mayo Clinic proceedings . 2009 Jul; 84(7): 632-638.
  30. Hodsman.A, Bauer.D, Dempster,D, Dian.L, Hanley.D, Harris.S, Kendler.D, McClung.M, Miller.P, Olszynski.W, Orwoll.E and Yuen.C. Parathyroid Hormone and Teriperatide for the Treatment of Osteoporosis: A Review of the Evidence and Suggested Guidelines for Its Use. Endocrine Reviews . Aug 2005; 26(5): 688-703.
  31. Body.J, Gaich.G, Scheele.W, Kulkarni.P, Miller.P, Peretz.A, Dore.R, Rotter.R, Papioannou.A, Cumming.D and Hodsman.A. A Randomized Double-Blind Trial to Compare the Efficacy of Teriperatide [Recombinant Human Parathyroid Hormone (1-34)] with Alendronate in Postmenopausal Women with Osteoporosis. The Journal of Clinical Endocrinology and Metabolism. 87(10): 4528-4535.
  32. Stroup.J, P-kane.M and Abu-Baker.A. Teriperatide in the Treatment of Osteoporosis. American Journal of Health System . Mar 15, 2005; Vol.65 (6): 532-539.
  33. VW B, J Br, The role of nutrition in osteoporosis. Br j biomed science. 1994; 51(3):228-40.
  34. AJ. C and FJ. R. Review of risk factors for osteoporosis with particular reference to possible etiological role of dietary salt.DOI . 2000; 38(2-30); 237-253.